Home›Trial›NCT07266818
🔬NCT07266818Phase 1ACTIVE NOT RECRUITING

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

Study Summary

The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.

Conditions
Healthy
Interventions / Drugs
MK-1167Placebo
View on ClinicalTrials.gov ↗
Sponsor
MRK
Merck & Co
Oncology/Vaccines
F34/100
Study Details
Enrollment30 participants
Primary Completion—
Lead SponsorMerck Sharp & Dohme LLC
Data Retrieved2026-04-11 02:55:36.204804+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.